ULTI Ultimovacs

Ultimovacs ASA: Invitation to Second Quarter 2021 Results Webcast Presentation

Ultimovacs ASA: Invitation to Second Quarter 2021 Results Webcast Presentation

OSLO, Norway, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, invites to a webcast presentation of its second quarter 2021 results on Friday 20 August 2021.

The presentation can be followed as a live webcast (access through link ) at 09:00 CET on Friday 20 August 2021. The webcast presentation will be available on the Ultimovacs website, and it will be possible to post questions during the presentation through the webcast.

The report and presentation will be available on the company website from 08:00 CET the same day.

For further information, please see or contact:

Carlos de Sousa, CEO

Email:

Phone:

Hans Vassgård Eid, CFO

Email:

Phone:

Mary-Ann Chang, LifeSci Advisors

Email:

Phone:  853



EN
11/08/2021

Underlying

ULTIUltimovacs

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ultimovacs

 PRESS RELEASE
Free
ULTI ULTIMOVACS

Zelluna ASA [ZLNA]: Notification of transaction by close associate of ...

Zelluna ASA [ZLNA]: Notification of transaction by close associate of primary insider Oslo, Norway, 4 April, 2025 - Reference is made to the stock exchange notice published by Zelluna ASA (the "Company") on 27 March 2025 regarding key information on the reverse share split at a ratio of 10:1. Radforsk Investeringsstiftelse ("Radforsk") has previously agreed with the Company to make available, without any compensation a, necessary number of shares to ensure that all fractions of shares are rounded up to the nearest whole share, thus avoiding that shareholders will have its shareholdings rou...

April 4, 2025 1 EN
 PRESS RELEASE
Free
ULTI ULTIMOVACS

Zelluna ASA [ZLNA]: Notice of Annual General Meeting on April 29, 2025

Zelluna ASA [ZLNA]: Notice of Annual General Meeting on April 29, 2025 Oslo, April 04, 2025, the Board of Directors hereby calls for the Annual General Meeting of Zelluna ASA at 14:00 CET on April 29, 2025.  The General Meeting will be held electronically. For participation, please log in at . All documents regarding the Annual General Meeting are available at the Company’s website: For further information, please contact: Anders Tuv, Chairman of the Board of Directors of Zelluna ASAEmail: Phone: Namir Hassan, CEO, Zelluna ASAEmail: Phone: Hans Vassgård Eid, CFO, Zelluna ASA Ema...

April 4, 2025 1 EN
 PRESS RELEASE
Free
ULTI ULTIMOVACS

Zelluna ASA [ZLNA]: Annual Report 2024

Zelluna ASA [ZLNA]: Annual Report 2024 Oslo, Norway, 02 April, 2025 - Zelluna ASA, a company pioneering allogeneic ‘off the shelf’ T Cell Receptor based Natural Killer (TCR-NK) cells for the treatment of cancer, announces that the Board of Directors of Zelluna ASA has approved the Annual Report for 2024.  Please find a PDF version of the annual report, as well as the report in European Single Electronic Format (ESEF), as attachments to this release. The Annual Report is also available at the company's website: This information is subject to the disclosure requirements pursuant to Section...

April 2, 2025 1 EN
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Alexander Krämer
04/01/25 April 1, 2025 1 EN
 PRESS RELEASE
Free
ULTI ULTIMOVACS

Zelluna ASA [ZLNA]: Ex reverse share split today

Zelluna ASA [ZLNA]: Ex reverse share split today Oslo, Norway, 1 April 2025 Issuer name: Zelluna ASAEx. date: 1 April 2025Type of corporate action: Reverse share split Other information:Reverse split ratio – ten (10) old shares give one (1) new share.New par value of NOK 1 per shareNew ISIN is NO 001 3524942. For further information, please contact: Hans Vassgård Eid, CFO, Zelluna ASAEmail: Phone: About Zelluna ASAZelluna’s mission is to deliver transformative treatments with the capacity to cure advanced solid cancers, in a safe and cost-efficient manner, to patients on a global sca...

April 1, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch